Cargando…
Comparison of a novel chemiluminescent based algorithm to three algorithmic approaches for the laboratory diagnosis of Clostridium difficile infection
BACKGROUND: Rapid commercial assays, including nucleic acid amplification tests and immunoassays for Clostridium. difficile toxins, have replaced the use of older assays. They are included in a two-step algorithm diagnosis, including first the detection of the glutamate dehydrogenase (GDH) as a scre...
Autores principales: | Goret, J., Blanchi, J., Eckert, C., Lacome, S., Petit, A., Barbut, F., Bébéar, C., Mégraud, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690238/ https://www.ncbi.nlm.nih.gov/pubmed/26705425 http://dx.doi.org/10.1186/s13099-015-0079-8 |
Ejemplares similares
-
Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies
por: Goret, J., et al.
Publicado: (2018) -
Comprehensive evaluation of chemiluminescent immunoassays for the laboratory diagnosis of Clostridium difficile infection
por: Makristathis, A., et al.
Publicado: (2017) -
Variability in testing policies and impact on reported Clostridium difficile infection rates: results from the pilot Longitudinal European Clostridium difficile Infection Diagnosis surveillance study (LuCID)
por: Davies, K., et al.
Publicado: (2016) -
Prevalence and pathogenicity of binary toxin–positive Clostridium difficile strains that do not produce toxins A and B
por: Eckert, C., et al.
Publicado: (2014) -
Virulence of new variant strains of Clostridium difficile producing only toxin A or binary toxin in the hamster model
por: Marvaud, J.-C., et al.
Publicado: (2019)